A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Clinical trial NCT07018713 · RECRUITING

Trial details

NCT number: NCT07018713
Sponsor: Merz Therapeutics GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Migraine

Start date: 2025-08-21
Primary completion: 2027-10-01
Enrollment: 780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.